Author:
Santos Sónia Martins,Cunha Susana,Baptista Rui,Monteiro Sílvia,Monteiro Pedro,Gonçalves Francisco,Pêgo Mariano
Reference21 articles.
1. EINSTEIN–PE Investigators, Büller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366(14):1287-1297.
2. 2. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998
3. 3. 158(6):585-593.http://www.ncbi.nlm.nih.gov/pubmed/9521222. Accessed June 29, 2016.
4. Critical review and update on the treatment of acute and chronic pulmonary embolism;Shapiro;J Pharm Pract,2016
5. Acute pulmonary embolism: risk stratification;Goldhaber;Pathophysiol Haemost Thromb,2006